查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1850408

手術影像市場按組件、技術、模式、移動性/安裝類型、影像解析度/格式、臨床用途和最終用戶分類 - 全球預測 2025-2032

Surgical Imaging Market by Component, Technology, Modality, Mobility & Installation, Imaging Resolution & Format, Clinical Application, End User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，手術影像市場將成長至 102.4 億美元，複合年成長率為 13.99%。

主要市場統計數據
基準年2024年 35.9億美元
預計2025年 41億美元
預測年份：2032年 102.4億美元
複合年成長率（%） 13.99%

臨床重點和技術進步的融合正在將外科影像轉變為手術卓越性和手術彈性的策略性推動因素

外科影像融合了先進的視覺化技術、手術效率和以病人為中心的診療概念，重塑了臨床醫師的術中決策方式。現代外科手術環境越來越依賴高保真影像來減少術中不確定性，實現更精準的切除、更有針對性的介入並改善手術結果。隨著數位化架構和微型成像技術的進步，外科團隊正在採用整合式視覺化平台，將即時成像與導航、擴增實境疊加和精簡的資料管理相結合。

如今，臨床醫生和醫院領導層需要兼具臨床清晰度和營運價值的解決方案。因此，供應商優先考慮可互通的架構和以使用者為中心的介面，以最大限度地減少急診護理中的工作流程摩擦。這不僅帶來了技術變革，也帶來了組織變革。包括外科專家、放射科、生物醫學工程和IT部門在內的多學科團隊必須圍繞影像處理主導流程的共用績效指標和管治達成一致。這種轉變有利於在影像品質、易用性以及與電子健康記錄和手術全期資訊系統的無縫整合之間取得平衡的系統。

展望未來，我們預計製造商和醫療保健系統之間的合作將進一步加強，重點關注可重複的結果和基於證據的程序標準化。投資決策將取決於影像解決方案能否顯著降低手術表現的差異性，同時透過培訓、服務和分析來支持其應用。簡而言之，手術成像正在從一種輔助工具發展成為實現卓越手術和營運韌性的策略推動者。

模態融合、軟體定義功能和價值驅動的籌資策略正在推動外科影像領域發生重大結構性變化

過去幾年，外科影像領域經歷了一場變革性的轉變，其範圍已從設備的逐步升級延伸至醫療服務提供和組織方式的系統性變革。一項根本性的變化是從單一模態工具轉向多模態生態系統，該生態系統融合了2D透視、斷層合成、基於CT的3D重建以及基於MRI的術中引導。這種融合增強了空間理解，並支持在照護端進行複雜的決策。

隨著各種成像模式的融合，基於軟體的影像處理也應運而生。人工智慧和先進的影像處理演算法已成為增強對比度、降低雜訊和自動化常規測量的核心。因此，影像處理供應商不僅在硬體保真度方面競爭，還在軟體功能方面競爭，以提高吞吐量和診斷信心。此外，無縫連接和標準化資料交換通訊協定正在促進影像處理實驗室與醫院基礎設施的整合，從而實現術中工作流程同步和回顧性結果分析。

經濟和監理力量也在重塑採購行為。醫療系統正在強調優先考慮總體擁有成本、保證運作、快速部署和可預測維護的服務模式。同時，臨床相關人員要求提供臨床效用和價值的證據，這些證據可以透過降低併發症發生率、縮短手術時間和改善功能結果來衡量。總而言之，這些變化迫使醫療服務提供者和供應商圍繞協作、數據豐富的夥伴關係關係調整其策略，以加速先進外科影像技術的普及並擴大臨床效益。

不斷變化的關稅壓力如何重塑整個外科成像供應鏈的籌資策略、製造足跡和供應商選擇

美國關稅情勢為採購、供應鏈規劃和供應商選擇帶來了新的考量，影響了整個外科影像生態系統的設備定價和籌資策略。關稅正在影響區域製造地的決策，導致一些供應商重新評估製造地和供應商契約，以減輕成本壓力。為此，一些公司正在探索雙重採購策略、近岸外包方案以及包含價格穩定條款和庫存緩衝的長期供應商協議，以保持臨床服務的連續性。

營運團隊和採購部門擴大將關稅因素納入採購計劃，評估採購現成庫存和等待更優惠關稅條款之間的利弊。因此，某些類別的影像設備的採購時間較長，資本規劃週期通常包含應對進口關稅波動的緊急準備金。這種趨勢也促使供應商提供靈活的商業條款，例如價格保證和延期交貨協議，以消除供應商的關稅相關風險。

從策略角度來看，關稅環境將加速供應商整合和本地合作模式。擁有成熟國內製造能力和強大本地服務網路的供應商將獲得顯著的競爭優勢，能夠更快地部署並降低生命週期物流成本，同時最大限度地降低跨境關稅波動帶來的風險。相關人員應預期，在受關稅影響的環境中，企業將尋求在成本、通路和營運確定性之間取得平衡，因此短期內合約框架、物流策略和供應商實質審查實務將持續調整。

可操作的分割情報，將影像技術、臨床應用和最終用戶環境結合起來，以加速採用和臨床整合

了解細分市場的動態對於使產品開發和上市策略與實際臨床需求保持一致至關重要。將技術分為2D和3D成像，2D成像包括立體定位成像和斷層合成成像，這些成像模式仍然適用於需要快速可視化和最小佔用空間的大批量手術。相較之下，3D成像細分為基於CT的3D系統和基於MRI的3D系統，後者專注於體積重建和軟組織造影，用於複雜的手術規劃和術中引導。

應用塑造了心血管、胃腸道、神經系統、整形外科和泌尿系統手術的臨床提案主張。心血管手術優先考慮高時間解析度和精確的血管可視化，以支持基於導管的手術；而消化器官系統和泌尿器官系統手術通常需要緊湊、靈活的成像系統，以便於內視鏡檢查。神經系統病例需要卓越的空間精確度和腦組織對比度，以指導切除手術並保留功能。整形外科注重骨骼細節和術中對位，以最佳化植入定位並最大限度地降低再次手術率。根據這些差異化的臨床需求客製化產品功能，可以提高產品被採用的可能性並加強臨床夥伴關係。

終端使用者細分透過將門診手術中心、診斷中心和醫院區分為不同的部署環境，進一步完善了部署策略。門診手術中心包括獨立中心和醫院附屬中心，這些中心優先考慮吞吐量和狹窄的手術範圍。診斷中心包括癌症中心和診斷影像中心，其中術前規劃、病變定位和切片檢查指導是關鍵用例。醫院分為私立和公立機構，以平衡更廣泛的手術組合、複雜的病例組合和密集的採購流程。認知到這些差異，提供者和供應商可以將解決方案的外形規格、服務模式和定價結構與每種客戶類型的業務現實和決策路徑相匹配。

區域動態和基礎設施差異將影響全球手術影像市場的採用路徑、監管反應和商業機會

區域動態對外科影像生態系統的技術採用、監管途徑和商業模式有重大影響。在美洲，醫療系統對能夠展現手術互通性並支援捆綁支付模式的整合解決方案表現出強烈的需求，而北美醫療中心通常優先考慮互通性、臨床證據和響應迅速的供應商支援網路。在該地區的部分地區，清晰的監管和成熟的報銷途徑有助於新型術中影像應用的早期臨床應用。

由於法規差異和醫療基礎設施的差異，歐洲、中東和非洲地區的採用模式也存在差異。西歐醫療機構在明確的醫療技術評估和臨床指南的支持下，通常會迅速採用先進的影像技術。在中東和非洲部分地區，對三級醫療中心和轉診醫院的投資正在推動人們對用於專科手術的高階影像處理平台的興趣，但嚴重的系統級容量限制可能會減緩採用速度。

在亞太地區，快速的基礎設施投資、不斷擴張的私人醫院網路以及對外科專科化的日益重視，為影像創新創造了肥沃的條件。擁有強大醫療設備生態系統的國家正在加速採用混合手術室和影像導引手術，而新興市場則優先考慮緊湊、經濟高效的解決方案，以滿足有限的資本預算。此外，對於尋求最佳化成本結構和縮短供應鏈的供應商來說，亞太地區正成為重要的製造和研發中心，從而影響全球部署時間表和商業夥伴關係。

競爭格局分析揭示了平台模組化、軟體差異化和服務卓越性如何推動供應商定位和夥伴關係

手術影像領域的競爭態勢主要集中在老牌設備製造商、專業軟體供應商以及專注於利基臨床應用的新興技術參與企業之間。現有的系統供應商持續投資模組化平台，這些平台可在多個手術室之間擴展功能，同時利用現有服務網路來確保執行時間和可預測的生命週期成本。同時，專業軟體公司憑藉先進的影像處理、導航演算法和分析技術脫穎而出，從影像資料集中挖掘臨床價值。

策略聯盟、定向收購和共同開發夥伴關係是當前活動的特徵，供應商正努力將無與倫比的硬體與軟體智慧和臨床工作流程專業知識相結合。這些聯盟通常優先考慮與電子健康記錄、雲端基礎分析和手術規劃工具的整合，以提供無縫的端到端工作流程。此外，供應商正在嘗試訂閱和基於結果的合約模式，將供應商的報酬與臨床表現掛鉤，為供應商提供了另一種無需大量前期投資即可獲得先進影像處理功能的途徑。

卓越的服務仍是競爭優勢。提供全面培訓、反應迅速的現場服務和主動零件管理的供應商，能夠確保更高的採用率和更高的生命週期價值。同時，那些帶來顛覆性功能（例如基於人工智慧的組織表徵或緊湊型術中磁振造影解決方案）的新參與企業，必須優先考慮嚴格的臨床檢驗和實施後支持，以贏得外科團隊和採購委員會的信任。

協調採購、互通性、商業化和臨床醫生採用以維持影像主導價值的實用策略建議

產業領導者應採取平衡近期業務重點與影像處理化醫療路徑長期策略投資的方法。首先，透過定義與影像投資相關的可衡量績效指標（例如降低再手術率和提高術中決策信心），使採購採購慣例與臨床結果目標一致。將採購決策與明確的臨床和財務指標掛鉤，有助於合理化資本配置，並確保外科、放射科和財務相關人員的跨職能支援。

其次，在評估新系統時，優先考慮互通性和開放標準。支援標準化資料交換並與導航、電子記錄和分析平台整合的架構可以減少實施阻力，並在數位架構發展過程中為您的投資提供面向未來的保障。第三，考慮靈活的商業模式，以降低關稅和供應鏈風險。這包括區域維護協議、延長保固期和分階段部​​署等選項，使您能夠分散資本風險，同時提升臨床能力。

第四，我們將透過結構化的培訓計畫、基於模擬的入職培訓和多學科管理，投資於臨床醫生的採用，將影像技術納入臨床方案。有效的變革管理將推動管治，並最大限度地提高技術投資回報。最後，我們將與學術中心和科技公司建立創新夥伴關係，試點基於人工智慧的組織描繪和擴增實境疊加等先進應用。

透過整合臨床醫生訪談、臨床文獻綜述和交叉檢驗的多方法研究途徑獲得基於證據的策略見解

本執行摘要所依據的研究結合了多種定性和定量方法，以確保獲得穩健的多觀點洞察。主要研究包括與不同類型和地區的醫院的臨床負責人、生物醫學工程師、採購負責人和產品經理進行結構化訪談。這些訪談重點在於臨床工作流程、採購標準以及術中影像實施的優先事項，從而提供有關營運限制和決策促進因素的第一手觀點。

二次研究包括對同行評審的臨床研究、監管備案文件、產品手冊和上市公司資訊揭露進行系統性回顧，以檢驗臨床聲明、技術能力和商業策略。分析框架整合了技術評估、應用映射和最終用戶細分，以得出切實可行的見解。每個階段的研究結果隨後與專家進行交叉驗證研討會，以協調相互衝突的輸入並檢驗假設的敏感性。

調查方法限制包括法規環境的區域差異和各機構報告標準的差異；這些問題已透過分層抽樣和敏感性分析得到解決。在適當的情況下，我們清楚地記錄了假設，並參考專家共識來解釋模糊或專有數據。這種混合方法提供了一種平衡的、基於證據的視角，旨在為外科影像診斷相關人員提供營運決策和策略規劃資訊。

綜合證據和策略，展示如何透過協作實施基於影像處理的工作流程來持續改善病患治療效果和業務績效

外科影像技術正從一項輔助技術轉變為現代外科醫療服務的核心組成部分，影響著臨床結果、工作流程設計和供應商生態系統。多模態影像、先進軟體和互聯工作流程的融合，為減少手術差異、提高手術精準度以及實現數據主導的改進週期創造了機會。同時，關稅趨勢進一步加劇了採購和供應鏈的複雜性，因此務實的籌資策略和靈活的商業性安排至關重要。

積極主動地將臨床目標與採購和供應商夥伴關係關係結合的組織，將獲得最大的利益。注重互通性、嚴格的臨床檢驗和全面的服務模式，將加速影像技術的採用，並將影像技術嵌入標準化的護理路徑。同時，能夠平衡硬體效能、軟體智慧和可靠服務的供應商將保持競爭優勢。

最終，取得進展的關鍵在於外科醫生、放射科醫生、生物醫學團隊和產業合作夥伴齊心協力，將影像處理技術實用化，並對患者照護和機構績效產生可衡量的影響。透過優先考慮證據、互通性和以臨床醫生為中心的設計，相關人員可以克服當前的困境，並將外科影像技術作為臨床差異化的永續來源。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 推出結合機器人手術和先進多模態影像診斷的混合手術室
  • 新興的微創螢光成像技術提高了腫瘤邊緣的可視化
  • 將擴增實境覆蓋整合到內視鏡手術中，以提供即時解剖指導
  • 術中錐狀射束CT 系統的進步可改善整形外科手術中的 3D 影像
  • 開發具有基於人工智慧的影像分析功能的可攜式手持超音波設備，用於照護現場診斷
  • 使用機器學習演算法最佳化術中透視系統中的輻射劑量
  • 造影超音波技術在微創手術中檢測肝臟腫瘤的商業化應用

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 外科影像市場（按組件）

  • 配件和耗材
    • 造影劑和染料（ICG）
    • 窗簾和罩子
  • 硬體
    • 電纜和連接
    • 相機鏡頭和瞄準鏡
    • 檢測器和感測器
    • 顯示和記錄器
    • 影像系統
    • 光源
  • 服務
    • 安裝和檢驗
    • 維護和維修
    • 託管服務
    • 培訓和教育
  • 軟體
    • 3D重建
    • 人工智慧應用
    • 劑量管理
    • 影像處理
    • 工作流程和 PACS 整合

9. 外科影像市場（按技術）

  • 2D成像
    • 立體定位成像
    • 斷層合成
  • 3D成像
    • 基於CT的3D
    • 基於MR的3D

第 10 章。按模式分類的手術影像市場

  • 內視鏡影像
  • 磁振造影
  • 光學和分子成像
    • NIR/ICG螢光
    • 光學同調斷層掃描
  • 手術顯微鏡
  • 超音波
  • X光和螢光透視
    • 固定C臂/血管造影術
      • 天花板安裝系統
      • 混合手術室系統
    • 術中 CT/O 臂
    • 移動式C臂
      • 全尺寸C臂
      • 迷你C臂

第 11 章：手術影像市場流動性與安裝

  • 固定的
    • 天花板式
    • 落地式
  • 移動的
    • 推車底座
  • 移動式龍門架/滑動磁鐵

12. 外科成像市場（按影像解析度和格式）

  • 4K
  • 8K
  • 顏色
  • 雙通道可見光/近紅外線
  • HD 1080p
  • 單色

13. 外科影像市場（依臨床應用）

  • 心血管系統
    • 血管內
    • 結構性心臟
  • 耳鼻喉科/頭頸科
    • 鼻竇
    • 顱底
  • 一般外科
    • 冒號
    • 肝膽系統
  • 神經外科
    • 功能性/DBS
    • 腫瘤切除術
  • 整形外科和創傷
    • 骨折固定
    • 脊椎手術
  • 泌尿系統和婦科
    • 子宮切除術
    • 攝護腺

第 14 章。按最終用戶分類的手術影像市場

  • 門診手術中心
  • 醫院
    • 學術醫療中心
    • 社區醫院
  • 專科診所及辦公室實驗室

第 15 章。按地區分類的手術影像市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第 16 章。按組別分類的手術影像市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第 17 章。按國家/地區分類的手術影像市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • GE HealthCare Technologies Inc.
    • Siemens Healthineers AG
    • Koninklijke Philips NV
    • Canon Medical Systems Corporation
    • FUJIFILM Holdings Corporation
    • Olympus Corporation
    • Stryker Corporation
    • Mindray Medical International Limited
    • Shimadzu Corporation
    • Hologic, Inc.
Product Code: MRR-501246437219

The Surgical Imaging Market is projected to grow by USD 10.24 billion at a CAGR of 13.99% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.59 billion
Estimated Year [2025] USD 4.10 billion
Forecast Year [2032] USD 10.24 billion
CAGR (%) 13.99%

How converging clinical priorities and technological advances are transforming surgical imaging into a strategic enabler of procedural excellence and operational resilience

Surgical imaging is at the confluence of advanced visualization, procedural efficiency, and patient-centered care, reshaping how clinicians approach intraoperative decision-making. Modern operating environments increasingly rely on high-fidelity imaging to reduce uncertainty during procedures, enabling more precise resections, targeted interventions, and improved outcomes. As digital architectures and miniaturized imaging technologies advance, surgical teams are adopting integrated visualization platforms that combine real-time imaging with navigation, augmented reality overlays, and streamlined data management.

Clinicians and hospital leaders now seek solutions that deliver both clinical clarity and operational value. Consequently, vendors prioritize interoperable architectures and user-centered interfaces that minimize workflow friction in high-acuity settings. The resulting shift is not merely technological; it is organizational. Cross-disciplinary teams, including surgical specialties, radiology, biomedical engineering, and IT, must align around shared performance metrics and governance for imaging-driven procedures. This transformation favors systems that balance image quality, ease of use, and seamless integration with electronic health records and perioperative information systems.

Looking ahead, the emphasis on reproducible outcomes and evidence-based procedure standardization will drive deeper collaboration between manufacturers and health systems. Investment decisions will hinge on the ability of imaging solutions to demonstrably reduce variability in procedural performance while supporting adoption through training, service, and analytics capabilities. In short, surgical imaging is evolving from an ancillary tool to a strategic enabler of procedural excellence and operational resilience.

Major structural changes in surgical imaging driven by modality convergence, software-defined capabilities, and value-oriented procurement strategies

Over the past several years, the surgical imaging landscape has experienced transformative shifts that extend beyond incremental device upgrades to systemic changes in how care is delivered and organized. One fundamental shift is the migration from single-modality tools toward multi-modal ecosystems that combine 2D fluoroscopy, tomosynthesis, CT-derived three-dimensional reconstructions, and MR-based intraoperative guidance. This amalgamation enhances spatial understanding and supports complex decision-making at the point of care.

Parallel to modality convergence is the rise of software-defined imaging. Artificial intelligence and advanced image-processing algorithms now play a central role in enhancing contrast, reducing noise, and automating routine measurements. Consequently, imaging vendors compete not only on hardware fidelity but on software capabilities that improve throughput and diagnostic confidence. Additionally, seamless connectivity and standardized data exchange protocols have catalyzed integration between imaging suites and the broader hospital infrastructure, enabling synchronized intraoperative workflows and retrospective outcome analytics.

Economic and regulatory forces have also reshaped procurement behaviors. Health systems emphasize total cost of ownership, uptime guarantees, and service models that prioritize rapid deployment and predictable maintenance. Simultaneously, clinical stakeholders demand evidence of clinical utility and value-measured through reductions in complication rates, shorter procedure times, or improved functional outcomes. Taken together, these shifts compel providers and suppliers to reorient strategies around collaborative, data-rich partnerships that accelerate adoption and scale the clinical benefits of advanced surgical imaging.

How evolving tariff pressures are reshaping procurement strategies, manufacturing footprints, and vendor selection across surgical imaging supply chains

The tariff landscape in the United States has introduced additional considerations for procurement, supply-chain planning, and vendor selection, affecting device pricing and sourcing strategies across the surgical imaging ecosystem. Tariffs influence decisions around regional manufacturing footprints, with some suppliers reassessing production locations and supplier contracts to mitigate cost exposure. In response, several organizations are exploring dual-sourcing strategies, nearshoring options, and longer-term supplier contracts that include price stabilization clauses and inventory buffering to preserve continuity of clinical services.

Operational teams and purchasing departments increasingly incorporate tariff scenarios into procurement timelines, evaluating the trade-offs between acquiring immediately available inventory versus waiting for products that can be sourced under more favorable customs conditions. As a result, procurement windows have lengthened for certain classes of imaging equipment, and capital planning cycles now more frequently include contingency allowances for import duty variability. These dynamics also incentivize vendors to offer flexible commercial terms that transfer some tariff-related risk away from the provider, such as price protection guarantees or deferred delivery agreements.

From a strategic perspective, the tariff environment accelerates vendor consolidation and local partnership models. Suppliers with established domestic manufacturing or robust localized service networks gain distinct competitive advantages because they can minimize exposure to cross-border tariff volatility while offering faster deployment and lower lifecycle logistics costs. In the near term, stakeholders should anticipate ongoing adjustments to contractual frameworks, logistics strategies, and vendor due diligence practices as organizations seek to balance cost, access, and operational certainty in a tariff-influenced environment.

Actionable segmentation intelligence that aligns imaging technologies, clinical applications, and end-user environments to accelerate adoption and clinical integration

Understanding segmentation dynamics is critical to aligning product development and go-to-market strategies with real-world clinical needs. When technologies are parsed into two-dimensional imaging and three-dimensional imaging, the two-dimensional category includes stereotactic imaging and tomosynthesis modalities that continue to serve high-volume procedures where rapid visualization and minimal footprint are paramount. In contrast, three-dimensional imaging subdivides into CT-based 3D systems and MR-based 3D systems that emphasize volumetric reconstruction and soft-tissue contrast for complex surgical planning and intraoperative guidance.

Applications shape clinical value propositions across cardiovascular, gastrointestinal, neurological, orthopedic, and urological procedures. Cardiovascular interventions prioritize high temporal resolution and precise vessel visualization to support catheter-based therapies, while gastrointestinal and urological procedures often call for compact, flexible imaging that fits within endoscopy suites. Neurological use cases demand exceptional spatial accuracy and brain-tissue contrast for resection guidance and functional preservation. Orthopedic implementations focus on bone detail and intraoperative alignment to optimize implant positioning and minimize revision rates. Tailoring product features to these differentiated clinical requirements increases adoption likelihood and reinforces clinical partnership.

End-user segmentation further refines deployment strategies, distinguishing ambulatory surgical centers, diagnostic centers, and hospitals as distinct adoption environments. Ambulatory surgical centers encompass both freestanding centers and hospital-associated centers that emphasize throughput and narrow procedural scopes. Diagnostic centers include cancer centers and imaging centers where preoperative planning, lesion localization, and biopsy guidance are primary use cases. Hospitals split into private and public institutions that balance broader procedural portfolios, complex case mixes, and centralized procurement processes. Recognizing these distinctions enables providers and vendors to match solution form factors, service models, and pricing structures to the operational realities and decision-making pathways of each customer type.

Regional dynamics and infrastructure variance that determine adoption pathways, regulatory readiness, and commercial opportunity across global surgical imaging markets

Regional dynamics exert a strong influence on technology adoption, regulatory pathways, and commercial models within the surgical imaging ecosystem. In the Americas, health systems exhibit a strong appetite for integrated solutions that demonstrate procedural efficiency and support bundled payment models, with North American centers often prioritizing interoperability, clinical evidence, and rapid vendor support networks. Regulatory clarity and established reimbursement pathways in portions of the region facilitate earlier clinical introduction for novel intraoperative imaging applications, although procurement cycles can remain elongated due to multi-stakeholder approvals.

In Europe, the Middle East & Africa, regulatory diversity and heterogeneity in healthcare infrastructure lead to differentiated adoption patterns. Western European centers frequently adopt advanced imaging modalities quickly when supported by clear health-technology assessments and clinical guideline endorsements, while other parts of the region require solutions that emphasize cost-effectiveness and adaptable service models. In the Middle East and parts of Africa, investment in tertiary centers and referral hospitals drives interest in high-end imaging platforms for specialized procedures, but broader system-level capacity constraints can slow diffusion.

Across the Asia-Pacific region, rapid infrastructure investment, expanding private hospital networks, and increasing emphasis on surgical subspecialization create fertile conditions for imaging innovation. Countries with strong medical-device ecosystems show accelerated uptake of hybrid operating rooms and image-guided surgery suites, whereas emerging markets prioritize compact and cost-effective solutions that fit constrained capital budgets. Moreover, the Asia-Pacific region is becoming an important manufacturing and R&D base for vendors looking to optimize cost structures and shorten supply chains, which in turn impacts global deployment timelines and commercial partnerships.

Competitive landscape analysis revealing how platform modularity, software differentiation, and service excellence drive vendor positioning and partnerships

Competitive dynamics in surgical imaging center on a mix of established device manufacturers, specialized software vendors, and emerging technology entrants that focus on niche clinical applications. Established system providers continue to invest in modular platforms that allow providers to scale functionality across multiple operating rooms while leveraging existing service networks to ensure uptime and predictable lifecycle costs. At the same time, specialist software firms are differentiating through advanced image processing, navigation algorithms, and analytics that extract incremental clinical value from imaging datasets.

Strategic alliances, targeted acquisitions, and co-development partnerships characterize current activity as vendors seek to pair hardware excellence with software intelligence and clinical workflow expertise. These collaborations often prioritize integration with electronic medical records, cloud-based analytics, and surgical planning tools to deliver seamless end-to-end workflows. Additionally, suppliers are experimenting with subscription and outcome-based contracting models that align vendor compensation with clinical performance, offering providers alternative ways to access advanced imaging capabilities without large upfront capital expenditure.

Service excellence remains a competitive differentiator. Vendors that offer comprehensive training, rapid field service, and proactive parts management secure stronger adoption and higher lifetime value. Meanwhile, newer entrants that bring disruptive capabilities-such as AI-driven tissue characterization or compact intraoperative MR solutions-must prioritize rigorous clinical validation and post-deployment support to gain the trust of surgical teams and procurement committees.

Practical strategic recommendations designed to align procurement, interoperability, commercialization, and clinician adoption for sustained imaging-driven value

Industry leaders should adopt a deliberate approach that balances near-term operational priorities with longer-term strategic investments in imaging-enabled care pathways. First, align procurement practices with clinical outcome objectives by defining measurable performance indicators tied to imaging investments, such as reductions in reoperation rates or improvements in intraoperative decision confidence. Linking purchasing decisions to clear clinical and financial metrics helps justify capital allocation and supports cross-functional buy-in across surgical, radiology, and finance stakeholders.

Second, prioritize interoperability and open standards when evaluating new systems. Solutions that support standardized data exchange and integrate with navigation, electronic records, and analytics platforms reduce implementation friction and future-proof investments against evolving digital architectures. Third, consider flexible commercial models that mitigate tariff and supply-chain risks, including options for localized maintenance agreements, extended warranties, and phased deployments that spread capital exposure while delivering incremental clinical capability.

Fourth, invest in clinician adoption through structured training programs, simulation-based onboarding, and multidisciplinary governance that embeds imaging into clinical protocols. Effective change management accelerates utilization and maximizes return on technology investments. Finally, cultivate innovation partnerships with academic centers and technology firms to pilot advanced applications-such as AI-assisted tissue delineation or augmented-reality overlays-under controlled study conditions that generate evidence for scaled adoption.

A multi-method research approach that integrates clinician interviews, clinical literature review, and cross-validation to produce evidence-grounded strategic insights

The research underpinning this executive summary combined multiple qualitative and quantitative approaches to ensure robust, multi-perspective insights. Primary research included structured interviews with clinical leaders, biomedical engineers, procurement executives, and product managers across diverse hospital types and geographic regions. These conversations focused on clinical workflows, procurement criteria, and priorities for intraoperative imaging adoption, providing firsthand perspectives on operational constraints and decision drivers.

Secondary research involved systematic review of peer-reviewed clinical studies, regulatory filings, product brochures, and public company disclosures to validate clinical claims, technological capabilities, and commercial strategies. The analytical framework integrated technology assessment with application mapping and end-user segmentation to generate actionable insights. Across stages, findings were triangulated through cross-validation workshops with subject-matter experts to reconcile conflicting inputs and test hypothesis sensitivity.

Limitations include variation in regional regulatory environments and heterogeneity in reporting standards across institutions, which the methodology accounted for through stratified sampling and sensitivity analyses. Where appropriate, assumptions were explicitly documented and expert consensus was used to interpret ambiguous or proprietary data. This mixed-methods approach yields a balanced, evidence-grounded perspective designed to inform operational decisions and strategic planning for stakeholders in surgical imaging.

Synthesis of evidence and strategy showing how collaborative adoption of imaging-enabled workflows can sustainably improve patient outcomes and operational performance

Surgical imaging is transitioning from a supporting technology to a central component of modern surgical care delivery, with implications for clinical outcomes, workflow design, and supplier ecosystems. The convergence of multi-modal imaging, advanced software, and connected workflows creates opportunities to reduce procedural variability, enhance surgical precision, and enable data-driven improvement cycles. At the same time, procurement and supply-chain complexities-heightened by tariff dynamics-require pragmatic sourcing strategies and flexible commercial arrangements.

Organizations that proactively align clinical goals with procurement and vendor partnerships stand to realize the greatest benefit. Emphasizing interoperability, rigorous clinical validation, and comprehensive service models will accelerate adoption and embed imaging within standardized care pathways. Meanwhile, vendors that marry hardware performance with software intelligence and dependable service will maintain competitive advantage.

Ultimately, the path forward rests on collaboration: between surgeons, radiologists, biomedical teams, and industry partners to operationalize imaging capabilities in ways that measurably improve patient care and institutional performance. By prioritizing evidence, interoperability, and clinician-centered design, stakeholders can navigate current headwinds and harness surgical imaging as a durable source of clinical differentiation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of hybrid operating rooms combining robotic surgery with advanced multimodal imaging
  • 5.2. Emergence of minimally invasive fluorescence imaging techniques to improve tumor margin visualization
  • 5.3. Integration of augmented reality overlays in endoscopic procedures for real-time anatomical guidance
  • 5.4. Advancements in intraoperative cone beam CT systems for enhanced 3D imaging during orthopedic surgeries
  • 5.5. Development of portable handheld ultrasound devices with AI-driven image analysis for point-of-care diagnostics
  • 5.6. Use of machine learning algorithms to optimize radiation dosing in intraoperative fluoroscopy systems
  • 5.7. Commercialization of contrast-enhanced ultrasound techniques for liver tumor detection in minimally invasive surgeries

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Surgical Imaging Market, by Component

  • 8.1. Accessories & Consumables
    • 8.1.1. Contrast Agents & Dyes (ICG)
    • 8.1.2. Drapes & Covers
  • 8.2. Hardware
    • 8.2.1. Cables & Connectivity
    • 8.2.2. Camera Heads & Scopes
    • 8.2.3. Detectors & Sensors
    • 8.2.4. Displays & Recorders
    • 8.2.5. Imaging Systems
    • 8.2.6. Light Sources
  • 8.3. Services
    • 8.3.1. Installation & Validation
    • 8.3.2. Maintenance & Repair
    • 8.3.3. Managed Services
    • 8.3.4. Training & Education
  • 8.4. Software
    • 8.4.1. 3D Reconstruction
    • 8.4.2. AI Applications
    • 8.4.3. Dose Management
    • 8.4.4. Image Processing
    • 8.4.5. Workflow & PACS Integration

9. Surgical Imaging Market, by Technology

  • 9.1. 2D Imaging
    • 9.1.1. Stereotactic Imaging
    • 9.1.2. Tomosynthesis
  • 9.2. 3D Imaging
    • 9.2.1. Ct-Based 3D
    • 9.2.2. Mr-Based 3D

10. Surgical Imaging Market, by Modality

  • 10.1. Endoscopic Imaging
  • 10.2. Magnetic Resonance
  • 10.3. Optical & Molecular Imaging
    • 10.3.1. NIR/ICG Fluorescence
    • 10.3.2. Optical Coherence Tomography
  • 10.4. Surgical Microscopy
  • 10.5. Ultrasound
  • 10.6. X-Ray & Fluoroscopy
    • 10.6.1. Fixed C-Arm/Angiography
      • 10.6.1.1. Ceiling-Mounted System
      • 10.6.1.2. Hybrid OR System
    • 10.6.2. Intraoperative CT/O-Arm
    • 10.6.3. Mobile C-Arm
      • 10.6.3.1. Full-Size C-Arm
      • 10.6.3.2. Mini C-Arm

11. Surgical Imaging Market, by Mobility & Installation

  • 11.1. Fixed
    • 11.1.1. Ceiling-Mounted
    • 11.1.2. Floor-Mounted
  • 11.2. Mobile
    • 11.2.1. Cart-Based
  • 11.3. Movable Gantry/Sliding Magnet

12. Surgical Imaging Market, by Imaging Resolution & Format

  • 12.1. 4K
  • 12.2. 8K
  • 12.3. Color
  • 12.4. Dual-Channel Visible/NIR
  • 12.5. HD 1080p
  • 12.6. Monochrome

13. Surgical Imaging Market, by Clinical Application

  • 13.1. Cardiovascular
    • 13.1.1. Endovascular
    • 13.1.2. Structural Heart
  • 13.2. ENT/Head & Neck
    • 13.2.1. Sinus
    • 13.2.2. Skull Base
  • 13.3. General Surgery
    • 13.3.1. Colorectal
    • 13.3.2. Hepatobiliary
  • 13.4. Neurosurgery
    • 13.4.1. Functional/DBS
    • 13.4.2. Tumor Resection
  • 13.5. Orthopedic & Trauma
    • 13.5.1. Fracture Fixation
    • 13.5.2. Spine Surgery
  • 13.6. Urology & Gynecology
    • 13.6.1. Hysterectomy
    • 13.6.2. Prostate

14. Surgical Imaging Market, by End User

  • 14.1. Ambulatory Surgical Centers
  • 14.2. Hospitals
    • 14.2.1. Academic Medical Centers
    • 14.2.2. Community Hospitals
  • 14.3. Specialty Clinics & Office-Based Labs

15. Surgical Imaging Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Surgical Imaging Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Surgical Imaging Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. Competitive Landscape

  • 18.1. Market Share Analysis, 2024
  • 18.2. FPNV Positioning Matrix, 2024
  • 18.3. Competitive Analysis
    • 18.3.1. GE HealthCare Technologies Inc.
    • 18.3.2. Siemens Healthineers AG
    • 18.3.3. Koninklijke Philips N.V.
    • 18.3.4. Canon Medical Systems Corporation
    • 18.3.5. FUJIFILM Holdings Corporation
    • 18.3.6. Olympus Corporation
    • 18.3.7. Stryker Corporation
    • 18.3.8. Mindray Medical International Limited
    • 18.3.9. Shimadzu Corporation
    • 18.3.10. Hologic, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL SURGICAL IMAGING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING RESOLUTION & FORMAT, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING RESOLUTION & FORMAT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CLINICAL APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL SURGICAL IMAGING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 15. GLOBAL SURGICAL IMAGING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL SURGICAL IMAGING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AMERICAS SURGICAL IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. NORTH AMERICA SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. LATIN AMERICA SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SURGICAL IMAGING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. EUROPE SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. MIDDLE EAST SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. AFRICA SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GLOBAL SURGICAL IMAGING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. ASEAN SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. GCC SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. EUROPEAN UNION SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BRICS SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. G7 SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. NATO SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 33. SURGICAL IMAGING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 34. SURGICAL IMAGING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. SURGICAL IMAGING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL SURGICAL IMAGING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL SURGICAL IMAGING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL SURGICAL IMAGING MARKET SIZE, BY COMPONENT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ACCESSORIES & CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CONTRAST AGENTS & DYES (ICG), BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DRAPES & COVERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HARDWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CABLES & CONNECTIVITY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CAMERA HEADS & SCOPES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DETECTORS & SENSORS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DISPLAYS & RECORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL SURGICAL IMAGING MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INSTALLATION & VALIDATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAINTENANCE & REPAIR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MANAGED SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TRAINING & EDUCATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D RECONSTRUCTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL SURGICAL IMAGING MARKET SIZE, BY AI APPLICATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL SURGICAL IMAGING MARKET SIZE, BY DOSE MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL SURGICAL IMAGING MARKET SIZE, BY IMAGE PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL SURGICAL IMAGING MARKET SIZE, BY WORKFLOW & PACS INTEGRATION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 2D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL SURGICAL IMAGING MARKET SIZE, BY STEREOTACTIC IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL SURGICAL IMAGING MARKET SIZE, BY TOMOSYNTHESIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL SURGICAL IMAGING MARKET SIZE, BY 3D IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CT-BASED 3D, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MR-BASED 3D, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MODALITY, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ENDOSCOPIC IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MAGNETIC RESONANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL & MOLECULAR IMAGING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL SURGICAL IMAGING MARKET SIZE, BY NIR/ICG FLUORESCENCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL SURGICAL IMAGING MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL SURGICAL IMAGING MARKET SIZE, BY SURGICAL MICROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL SURGICAL IMAGING MARKET SIZE, BY ULTRASOUND, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL SURGICAL IMAGING MARKET SIZE, BY X-RAY & FLUOROSCOPY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED C-ARM/ANGIOGRAPHY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL SURGICAL IMAGING MARKET SIZE, BY HYBRID OR SYSTEM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL SURGICAL IMAGING MARKET SIZE, BY INTRAOPERATIVE CT/O-ARM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE C-ARM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FULL-SIZE C-ARM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MINI C-ARM, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILITY & INSTALLATION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FIXED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CEILING-MOUNTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL SURGICAL IMAGING MARKET SIZE, BY FLOOR-MOUNTED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOBILE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 315. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 316. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 317. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 318. GLOBAL SURGICAL IMAGING MARKET SIZE, BY CART-BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 319. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOVABLE GANTRY/SLIDING MAGNET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 320. GLOBAL SURGICAL IMAGING MARKET SIZE, BY MOVABLE GANTRY/SLIDING MAGNET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 321. GLOBAL SUR